Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results

COVID-19

Authors

López Fernández, M.J.; Narejos, S.; Castro, A.; Echave-Sustaeta, J.M.; Forner, M.J.; Arana-Arri, E.; Molto, J.; Bernad, L.; Pérez-Caballero, R.; Prado, J.G.

Appeared in

Vaccines

Global COVID-19 vaccination adapts to protect populations from emerging variants. This communication presents interim findings from the new Omicron XBB adapted PHH-1V81 vaccine compared to a XBB adapted mRNA vaccine against XBB and JN.1 SARS-CoV-2 strains.

Learn more